Document is current

Any future updates will be listed below

Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

Crossref DOI link: https://doi.org/10.1007/s12072-018-9876-8

Published Online: 2018-06-11

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark